|
|
|
| | |
Discussion forum - BSH 2020 VIRTUAL Topic - Lymphoma/CLL
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER. |
|
|
| | |
|
|
|
|
Poster: 92
Visits: 31
Title: Safety, efficacy and tolerability of the NORDIC regimen in the front-line treatment of transplant-eligible patients with mantle cell lymphoma
Authors: Jake Tobin , Jake Tobin:Department of Haematology,University Hospitals of Derby and Burton NHS Foundation Trust,Derby,United Kingdom|Adrian Smith:Department of Haematology,University Hospitals of Derby and Burton
Centre:
|
|
You must be registered to reply or comment.
|
|
SAFETY, EFFICACY AND TOLERABILITY OF THE NORDIC REGIMEN IN THE FRONT-LINE TREATMENT OF TRANSPLANT-ELIGIBLE PATIENTS WITH MANTLE CELL LYMPHOMA
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 1
Visits: 536
Title: Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial
Authors: Daniel Leongamornlert , E. Barretta, S. Lee, T. Creasey, R. Mitchell, A. A. Kirkwood, L Clifton-Hadley, P. Patrick, P. Campbell, B. Patel, A. Moorman, A. K. Fielding, E. Papaemmanuil
Centre:
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 81
Visits: 112
Title: Updated Results of a Phase Ib/II Randomised Study: Polatuzumab Vedotin (Pola) Plus Bendamustine (B) and Rituximab (R) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Authors: Elaine Kamara , L.H. Sehn, M.J. Matasar, C.R. Flowers, M. Kamdar, A.K. McMillan, M. Hertzberg, S. Assouline, T.M. Kim, W.S. Kim, M. Ozcan, B. Croft, J. Hirata, J. Cheng, G. Ku, A.F. Herrera
Centre:
|
|
|
|